Combination of N, N′‐dicyclohexyl‐N‐arachidonic acylurea and tacrolimus prolongs cardiac allograft survival in mice

Abstract

Current immunosuppressive agents for organ transplantation are not ideal because of their strong toxicity and adverse effects. Hence, there is an urgent need to develop novel immunosuppressive agents. The compound N, N 0dicyclohexyl-N-arachidonic acylurea (DCAAA) is a novel highly unsaturated fatty acid from the traditional Chinese medicinal plant Radix Isatidis. In this study, we systematically investigated the toxicity, immunosuppressive effect and mechanisms underlying the activity of DCAAA. The toxicity tests showed that DCAAA treatment did not lead to red blood cell hemolysis and did not affect the liver and kidney functions in mice. The lymphocyte transformation test showed that DCAAA treatment inhibited lymphocyte proliferation in a dosedependent manner. An in vivo cardiac allotransplantation experiment showed that DCAAA treatment could suppress the immune rejection and significantly prolong the survival of cardiac allografts in recipient mice by reducing the proportion of CD4 + T cells in the spleen and grafts, concentration of interferon-c in the supernatant and serum and infiltration of inflammatory cells into the grafts. Moreover, a combination treatment with DCAAA and tacrolimus had a synergistic effect in preventing acute rejection of heart transplants. In vitro molecular biology experiments showed that DCAAA treatment inhibited activation of the T-cell receptor-mediated phosphoinostide 3-kinase-protein kinase B pathway, thereby arresting cell cycle transition from the G 1 to the S phase, and inhibiting lymphocyte proliferation. Overall, our study reveals a novel, low-toxicity immunosuppressive agent that has the potential to reduce the toxic side effects of existing immunosuppressive agents when used in combination with them.

MSR405: Inhibiting Neuroinflammation after Spinal Cord Injury in Rats

“…Similar homologous compounds have been administered via gavage for other diseases and have shown significant effects (such as N , N ′-dicyclohexyl- N -arachidonic acylurea, α-Linolenic acid) [ 46 , 47 ]. In our study, we used intraperitoneal injections, which showed no first pass eliminations and higher fractions of bioavailability compared to gavage.…”

Xiao-Yin-Fang Therapy Alleviates Psoriasis-like Skin Inflammation Through Suppressing γδT17 Cell Polarization

“…As bacterial infection has been reported to trigger and aggravate psoriasis, Banlangen contained multiple organic acids with potent antimicrobial activities, which included syringic acid, 2-amino-benzoic acid, salicylic acid and benzoic acid (Kong et al, 2008a;Kong et al, 2008b). Besides, N, N′-dicyclohexyl-N-arachidonic acylurea, a highly unsaturated fatty acid from Balangen, could inhibit TCRmediated PI3K-Akt signaling pathway, resulting in arrested cell cycle transition from G1 to S phase and lymphocyte hypoproliferation (An et al, 2020). Erucic acid, an active component of Banlangen, markedly reduced CD8 + cytotoxic T lymphocyte recruitment (Liang et al, 2020).…”